Roth Capital Starts Nektar Therapeutics (NKTR) at Buy

May 24, 2012 9:22 AM EDT Send to a Friend
Get Alerts NKTR Hot Sheet
Price: $10.75 --0%

Rating Summary:
    7 Buy, 1 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 1 | Down: 0 | New: 0
Trade NKTR Now!
Join SI Premium – FREE
Roth Capital initiates coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy. PT $10.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $6.97 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment